WaveMan · Form 4
Versant Venture Capital VI, L.P. insider trades
> Search tickers & screens ⌘K
LIVE

Versant Venture Capital VI, L.P. insider trades

Versant Venture Capital VI, L.P. has filed 7 Form 4s with the SEC that we hold, for LENZ Therapeutics, Inc. (LENZ) (10% owner), Monte Rosa Therapeutics, Inc. (GLUE) (10% owner), OYST (10% owner) and Tempest Therapeutics, Inc. (TPST) (10% owner). Across all of them we count 0 purchases worth $0 and 20 sales worth $34.0M reported on Form 4. None of these purchases or sales is dated in the last 12 months. The largest single trade was a sale of 1,132,566 shares of Monte Rosa Therapeutics, Inc. worth $7.4M, dated 2024-09-20. The first filing on our record is dated 2021-10-20 and the latest 2025-09-22.

LENZ Therapeutics, Inc. (LENZ)

10% owner · 2 filings · 10 purchases and sales
Trade dateCodeSharesValue as filedFiled
2025-08-15S, sale reported on Form 469,949$2.8M2025-08-19
2025-08-15S, sale reported on Form 4145,051$5.7M2025-08-19
2025-08-18S, sale reported on Form 415,085$581.7K2025-08-19
2025-08-18S, sale reported on Form 430,628$1.2M2025-08-19
2025-09-18S, sale reported on Form 449,479$2.1M2025-09-22
2025-09-18S, sale reported on Form 424,370$1.0M2025-09-22
2025-09-18S, sale reported on Form 4132$5.7K2025-09-22
2025-09-18S, sale reported on Form 420,148$866.4K2025-09-22
2025-09-18S, sale reported on Form 4268$11.6K2025-09-22
2025-09-18S, sale reported on Form 440,907$1.8M2025-09-22

Monte Rosa Therapeutics, Inc. (GLUE)

10% owner · 2 filings · 4 purchases and sales
Trade dateCodeSharesValue as filedFiled
2024-09-20S, sale reported on Form 41,132,566$7.4M2024-09-24
2024-10-28S, sale reported on Form 489,990$869.3K2024-10-30
2024-10-29S, sale reported on Form 415,600$146.8K2024-10-30
2024-10-29S, sale reported on Form 452,305$474.9K2024-10-30

OYST

10% owner · 2 filings · 4 purchases and sales
Trade dateCodeSharesValue as filedFiled
2021-10-18S, sale reported on Form 4303,614$4.4M2021-10-20
2021-10-18S, sale reported on Form 41,531$23.1K2021-10-20
2021-10-18S, sale reported on Form 4242,943$3.7M2021-10-20
2021-10-18S, sale reported on Form 41,912$28.0K2021-10-20

Tempest Therapeutics, Inc. (TPST)

10% owner · 1 filing · 2 purchases and sales
Trade dateCodeSharesValue as filedFiled
2024-08-08S, sale reported on Form 4400,000$540.0K2024-08-12
2024-08-12S, sale reported on Form 4387,999$426.8K2024-08-12
Source

Counted from the Form 4 filings this reporting owner (SEC CIK 1687880) filed on EDGAR. Values are the transaction values as filed. See every filing on EDGAR, or browse insider buying and today's insider purchases.

Source: U.S. Securities and Exchange Commission (EDGAR) and other official government data · Updated 2026-10-12 · For informational purposes only, not investment advice.
Privacy · Terms